TABLE 3.

Percent immunoreactivity with NS5A recombinant antigens derived from different HCV sequence variants of serum specimens obtained from patients infected with different genotypes

Serum genotype	% Immunoreactivity with NS5A proteins of indicated genotype
	1					2		3		4	5	6
	1a	1b-1	1b-2	1b-3	1c	2a	2b	3a	3b	4a	5a	11	6a
1 (n = 17)	88	94	100	94	94	88	6	100	94	100	88	88	11
2 (n = 17)	10	65	82	71	59	71	52	76	71	65	59	53	18
3 (n = 16)	87	93	100	93	88	88	0	100	93	93	100	100	25
4 (n = 5)	80	100	100	100	100	80	0	100	100	100	100	100	20
5 (n = 3)	67	67	100	0	67	67	0	67	67	100	67	100	33
6 (n = 3)	33	67	67	67	100	67	0	100	100	100	67	67	0
Total (n = 61)	62	84	93	84	82	77	16	92	87	92	82	84	18